FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series C / Health care startups that raised Series C in Massachusetts, United States

Health care startups that raised Series C in Massachusetts, United States

Updated 16 Nov 2026

Reset
Health care startups that raised Series C in Massachusetts, United States
One-time CSV
  • 97 funded companies, 89 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-c~massachusetts-united-states.csv97 rows × 18 columns
CompanyCityLast roundAmountDate
Delix TherapeuticsBostonSeries C$100.0M2026-11-09
Ratio TherapeuticsBostonSeries C$70.0M2026-07-31
Triveni BioWatertownSeries C$65.0M2026-06-17
InStride HealthBostonSeries C$30.0M2026-06-15
CereVascCharlestownSeries C$85.0M2026-06-04
CerevanceBostonSeries C$20.0M2026-05-12
Iterative HealthCambridgeSeries C$77.0M2026-04-30
AcuityMDBostonSeries C$80.0M2026-04-21

8 rows of the CSV in 5 of its 18 columns.

97
Startups
$11.3B
Total raised
14
Funded in the last 12 months
$825.0M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

20 of 97
20 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston Series C $100.0M 2026-11-09 $244.1M Gaingels, RA Capital Management, Dolby Family Ventures +2 11 to 50 2019
Ratio Therapeutics Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. Biotech Boston Series C $70.0M 2026-07-31 $160.0M Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments 11 to 50 2021
Triveni Bio Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. Biotech Watertown Series C $65.0M 2026-06-17 $272.0M Polaris Partners, OrbiMed, Alexandria Venture Investments +2 11 to 50 2019
InStride Health InStride Health provides evidence-based OCD and anxiety treatment to children and teenagers. Health care Boston Series C $30.0M 2026-06-15 $86.0M General Catalyst, .406 Ventures, Mass General Brigham Ventures +2 251 to 500 2021
CereVasc CereVasc develops a minimally invasive treatment for communicating hydrocephalus. Biotech Charlestown Series C $85.0M 2026-06-04 $199.0M Perceptive Advisors, Bain Capital Life Sciences, ATON Partners 11 to 50 2014
Cerevance Cerevance develops novel therapeutics for neurological diseases. Biotech Boston Series C $20.0M 2026-05-12 $209.5M Google Ventures, Casdin Capital, Foresite Capital +1 51 to 100 2016
Iterative Health Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. Artificial intelligence Cambridge Series C $77.0M 2026-04-30 $268.6M Plug and Play, Alumni Ventures, Insight Partners +1 251 to 500 2017
AcuityMD AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. Artificial intelligence Boston Series C $80.0M 2026-04-21 $163.0M Redpoint, Benchmark, ICONIQ Growth +2 251 to 500 2019
Terrestrial Bio Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. Biotech Cambridge Series C $50.0M 2026-03-26 $180.9M RA Capital Management, National Institutes of Health, The Engine 11 to 50 2012
Cognito Therapeutics Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. Biotech Cambridge Series C $105.0M 2026-03-05 $321.8M Morningside, FoundersX Ventures, IAG Capital Partners +1 11 to 50 2016
NanoHive Medical NanoHive Medical makes 3D-printed spinal interbody implants and instruments. Health care Woburn Series C $7.0M 2024-08-05 $7.0M Sky Ventures Group 11 to 50 2014
Sionna Therapeutics Sionna Therapeutics develops small molecule therapies for treating cystic fibrosis. Biotech Natick Series C $182.0M 2024-03-06 $292.0M RA Capital Management, OrbiMed, T. Rowe Price +2 11 to 50 2018
Overjet Overjet is a software company that offers an AI platform for dentistry and educates patients. Artificial intelligence Boston Series C $53.2M 2024-03-05 Insight Partners, General Catalyst, Liquid 2 Ventures +2 101 to 250 2018
Accent Therapeutics Accent Therapeutics is a biopharmaceutical company. Biotech Lexington Series C $75.0M 2024-01-23 $178.0M Google Ventures, Mirae Asset Venture Investment, Bristol-Myers Squibb +2 11 to 50 2017
Access Vascular Access Vascular develops novel hydrophilic-based medical devices that improve venous access. Health care Bedford Series C $22.0M 2023-10-31 $57.1M MedTech Innovator, TVM Capital Life Science, AngelMD 11 to 50 2015
IntelyCare Unicorn IntelyCare provides a workforce management platform for healthcare staffing, scheduling, and training. Health care Quincy Series C $115.0M 2022-04-06 $170.8M LRVHealth, Eastward Capital Partners, Longitude Capital +2 251 to 500 2014
ConcertAI Unicorn ConcertAI sells AI-powered SaaS data tools for medical research in oncology. Artificial intelligence Cambridge Series C $150.0M 2022-03-29 $300.0M Maverick Ventures, Sixth Street, Declaration Partners +2 1,001 to 5,000 2018
Hospital IQ Hospital IQ provides a web-based analytics platform that helps hospitals improve operational efficiency. Health care Newton Series C $25.0M 2021-06-28 $48.2M Longworth Venture Partners, Open Field Capital, Health Velocity Capital 11 to 50 2013
SupplyScape SupplyScape provides electronic pedigree solutions for the pharmaceutical industry. Health care Woburn Series C $10.0M 2007-09-06 $29.0M Flybridge, Chiratae Ventures, North Bridge Venture Partners & Growth Equity +1 251 to 500 2003
deNovis deNovis provides transaction processing and information management software for health insurers. Commerce Lexington Series C $22.0M 2004-01-12 3i Group, Bain Capital, JP Morgan Chase +2 1999

Table 1. Health care startups that raised Series C in Massachusetts, United States: the 20 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 97.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Cognito Therapeutics Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. Biotech Cambridge Series C $105.0M 2026-03-05 $321.8M Morningside, FoundersX Ventures, IAG Capital Partners +1 11 to 50 2016
2 Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston Series C $100.0M 2026-11-09 $244.1M Gaingels, RA Capital Management, Dolby Family Ventures +2 11 to 50 2019
3 CereVasc CereVasc develops a minimally invasive treatment for communicating hydrocephalus. Biotech Charlestown Series C $85.0M 2026-06-04 $199.0M Perceptive Advisors, Bain Capital Life Sciences, ATON Partners 11 to 50 2014
4 AcuityMD AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. Artificial intelligence Boston Series C $80.0M 2026-04-21 $163.0M Redpoint, Benchmark, ICONIQ Growth +2 251 to 500 2019
5 Iterative Health Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. Artificial intelligence Cambridge Series C $77.0M 2026-04-30 $268.6M Plug and Play, Alumni Ventures, Insight Partners +1 251 to 500 2017
6 Ratio Therapeutics Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. Biotech Boston Series C $70.0M 2026-07-31 $160.0M Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments 11 to 50 2021
7 Triveni Bio Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. Biotech Watertown Series C $65.0M 2026-06-17 $272.0M Polaris Partners, OrbiMed, Alexandria Venture Investments +2 11 to 50 2019
8 Terrestrial Bio Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. Biotech Cambridge Series C $50.0M 2026-03-26 $180.9M RA Capital Management, National Institutes of Health, The Engine 11 to 50 2012
9 InStride Health InStride Health provides evidence-based OCD and anxiety treatment to children and teenagers. Health care Boston Series C $30.0M 2026-06-15 $86.0M General Catalyst, .406 Ventures, Mass General Brigham Ventures +2 251 to 500 2021
10 Cerevance Cerevance develops novel therapeutics for neurological diseases. Biotech Boston Series C $20.0M 2026-05-12 $209.5M Google Ventures, Casdin Capital, Foresite Capital +1 51 to 100 2016

Table 2. Health care startups that raised Series C in Massachusetts, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 RA Capital Management Startup incubator Boston, United States 4 4% 2 Delix Therapeutics, Terrestrial Bio
2 Invus Private equity firm New York, United States 3 3% 1 Triveni Bio
3 Polaris Partners Private equity firm Boston, United States 3 3% 1 Triveni Bio
4 OrbiMed Private equity firm New York, United States 3 3% 1 Triveni Bio
5 Google Ventures Corporate venture arm San Francisco, United States 3 3% 1 Cerevance
6 F-Prime Venture capital firm Cambridge, United States 3 3%
7 Bristol-Myers Squibb Venture capital firm New York, United States 2 2% 1 Ratio Therapeutics
8 .406 Ventures Venture capital firm Boston, United States 2 2% 1 InStride Health
9 General Catalyst Venture capital firm San Francisco, United States 2 2% 1 InStride Health
10 Insight Partners Private equity firm New York, United States 2 2% 1 Iterative Health
11 Longitude Capital Venture capital firm Menlo Park, United States 2 2%
12 MedTech Innovator Startup accelerator Los Angeles, United States 2 2%
13 Janus Henderson Investors Private equity firm London, United Kingdom 2 2%
14 The Blue Venture Fund Private equity firm Chicago, United States 2 2%
15 Eight Roads Ventures Venture capital firm London, United Kingdom 2 2%

Table 3. Health care startups that raised Series C in Massachusetts, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 65 67% $9.3B
Software 26 27% $2.8B
Artificial intelligence 10 10% $1.7B
Hardware 3 3% $369.5M
Commerce 2 2% $56.9M
Education 1 1% $12.0M
Fintech 1 1%

Table 4. Health care startups that raised Series C in Massachusetts, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series C 97 100% $37.0M

Table 5. Health care startups that raised Series C in Massachusetts, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Boston 29 30%
Cambridge 26 27%
Woburn 7 7%
Waltham 6 6%
Lexington 3 3%
Watertown 2 2%
Charlestown 2 2%
Andover 2 2%
Framingham 2 2%
Mansfield 2 2%
Burlington 1 1%
Natick 1 1%

Table 6. Health care startups that raised Series C in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 2 14% $115.0M
September 2026 1 7% $6.0M
July 2026 2 14% $107.0M
June 2026 4 29% $265.0M
May 2026 1 7% $20.0M
April 2026 2 14% $157.0M
March 2026 2 14% $155.0M

Table 7. Health care startups that raised Series C in Massachusetts, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 14 14% $825.0M
2025 11 11% $642.7M
2024 7 7% $674.5M
2023 4 4% $179.5M
2022 9 9% $771.9M
2021 8 8% $352.0M

Table 8. Health care startups that raised Series C in Massachusetts, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 7 7%
2015 to 2019 38 39%
2010 to 2014 22 23%
Before 2010 30 31%

Table 9. Health care startups that raised Series C in Massachusetts, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 5 5%
11 to 50 41 43%
51 to 100 23 24%
101 to 250 16 17%
251 to 500 8 8%
501 to 1,000 2 2%
1,001 to 5,000 1 1%

Table 10. Health care startups that raised Series C in Massachusetts, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Massachusetts, United States whose last round is Series C are on the list?
97, in the file dated 16 November 2026. 14 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 97 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series C in Massachusetts, United States: 97 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Massachusetts

Other sectors that raised Series C in Massachusetts

Cite: FundingWatcher, 97 health care companies in Massachusetts, United States whose most recent round is Series C, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-c/massachusetts-united-states/